Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Peter Silburn

Peter Silburn

The University of Queensland , Australia

MAS Ahmed

MAS Ahmed

Queen’s Hospital UK

Noboru Imai

Noboru Imai

Japanese Red Cross Shizuoka Hospital, Japan

Zhoulei Li

Zhoulei Li

Institute of Helmholtz Center Munich Gibraltar

Steven Benvenisti

Steven Benvenisti

Partner at Davis, Saperstein & Salomon Personal Injury Law Firm NJ & USA

Kuldip Sidhu

Kuldip Sidhu

CEO & Founding Director Cell Therapeutics Pty Lt Australia

Joanna B. Strosznajder

Joanna B. Strosznajder

Polish Academy of Sciences Poland

Yuri P Danilov

Yuri P Danilov

University of Wisconsin-Madison USA

Recommended Global Psychiatry Webinars & Conferences

Asia Pacific & Middle East


About Us

We welcome you all to attend the“4th Annual Congress on Mental Health & Psychiatry” scheduled during November 20-21, 2023 at Dubai, UAE. The main theme of the conference is “Modernizing and Accomplishing Mental wellness through Psychology and Psychiatric Empathy”. Join this intimate forum to create meaningful partnerships with 50+ Neuroscience experts. Translate key technological & mechanistic neuroscience advances into the clinic. This congress will deliver new notions, principles, strategies and maneuver’s where no conference will offer and a remarkable list of Keynote speakers, quality attendees, and compelling content. The various thematic sessions will be discussed at this conference; we welcome all of you to attend the conference.

Our goal is to bring together worldwide distinguished academics in the field of Neuroscience and Psychiatry to exchange and share meaningful experiences of various treatment procedures for mental health, neurological disorders and stroke.

We soulfully welcome you to Mental Health Annual Congress 2023 will inspire you and will result in new collaborations and friendships!

Scientific Sessions

Track 1: Mental health

Mental health denotes to cognitive, behavioral, and expressive well-being. It is totally about how people think, feel, and behave. People at times use the term “mental health” to mean the absence of a mental disorder. Observing after mental health can preserve a person’s ability to enjoy life. Doing this includes reaching a balance between life activities, responsibilities, and efforts to achieve psychological resilience. Conditions such as stress, depression, and anxiety can completely affect mental health and disrupt a person’s routine. Although the term mental health is in common use, several conditions that doctors recognize as psychological disorders have physical roots.

Track 2: Stress, Anxiety and Depression

The overwhelming majority encounter stress and nervousness every once during a while. Stress is any request placed on your cerebrum or human body. Individuals can report feeling focused when various contending requests are placed on them. The sentiments being focused are often activated by an event that influences you to feel baffled or anxious. Tension may be a sentiment dread, stress, or unease. It are often a response to worry, or it can happen in individuals who can't distinguish noteworthy stressors throughout their life.

Track 3: Psychotherapy and Psychosomatic Medicine

Psychotherapy, often known as psychological treatment, talk therapy, or talking therapy, is the application of psychological techniques to assist a person in altering behaviour, enhancing happiness, and resolving issues. An interdisciplinary medical specialty called "psychosomatic medicine" studies the effects of social, psychological, and behavioural factors on physical functions and quality of life in both people and animals. Psychosomatic disorders, in which mental elements significantly influence the onset, manifestation, or remission of a physical illness, are distinguished from somatoform illnesses, in which mental aspects are the only contributing factor to a physical illness.

Track 4: Addictive Disorders

Addictive disorders, such as substance abuse and dependence, are common disorders that involve the overuse of alcohol and drugs. Addiction develops over time and is a chronic and relapsing illness. In most cases, people with addictions frequently suffer from a mental illness, such as depression, anxiety or another disorder. Addictive disorders are caused by multiple factors, including genetic vulnerability, environmental stressors, social pressures, individual personality characteristics and psychiatric problems.

From a neurological standpoint, addictive disorders arise when a substance changes the way the user’s brain feels pleasure. Addictive substances alter the brain’s ability to send and receive chemicals called neurotransmitters, which cause pleasure. The addictive substances can prevent nerves in the brain (called neurons) from receiving these neurotransmitters, meaning the drug user relies on the drug, rather than his or her natural brain chemicals, for feelings of pleasure.

Track 5: Child and Adolescent Mental Health

The child and adolescent Psychiatry is dealt by the therapist who works in the analysis and the treatment of issues of reasoning, feeling or potentially conducts influencing youngsters, teenagers, and their families. A child and adolescent therapist offers families the upsides of clinical instruction, the clinical customs of expert morals, and clinical obligation regarding giving exhaustive consideration. It researches the biopsychosocial factors that impact the turn of events and course of mental problems and treatment reactions to different intercessions. Child and adolescent specialists fundamentally use psychotherapy or potentially drug to treat mental issues in the pediatric populace.

Track 6: Bipolar disorder & Schizophrenia

Bipolar disorder and Schizophrenia are severe mental illnesses commonly referred to as psychotic disorders, meaning symptoms can include psychosis—impaired thoughts and emotions severe enough to induce a disconnect from reality. Bipolar disorder causes severe shifts in mood, ranging from depressive lows to manic highs. Schizophrenia is a chronic and severe mental health disorder that affects how a person thinks feels and behaves. People with schizophrenia may seem like they have lost touch with reality and can experience hallucinations, delusions, and disorganized thinking.

Track 7: Autism Spectrum Disorder

Autism also named autism spectrum disorder (ASD) is a complicated condition that contains problems with communication and behavior. People with autism have trouble with communication. People with Autism have trouble understanding what other people think and feel about them. Autism spectrum disorder is a disorder associated to brain development that effects how a person witnesses and socializes with others causing problems in social interaction and communication. The disorder also covers limited and repetitive patterns of behavior.

Track 8: Psychoanalysis

Psychoanalysis is defined as a set of psychological theories and therapeutic techniques that which have their origin in the work with theories of Sigmund Freud. The core of psychoanalysis is the belief that all people possess unconscious thoughts feelings and desires and memories.          

Track 9: Post-Traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) may be a sort of anxiety illness that a private could develop when being concerned about, or witnessing any traumatic events. The disorder was initial recognized in troopers and has been recognized by multiple names, reminiscent of 'shell shock. However, it is not solely diagnosed in troopers however conjointly a good variety of excruciating experiences will cause anxiety disorder. Anxiety disorder could also be represented contrarily in some situations: if an associate degree individual’s symptoms develop over six months when experiencing trauma, this may well be selected as 'delayed PTSD'. If someone has old trauma at an associate degree early age or it continued for an extended time, you would possibly be associate degree analysis of 'complex PTSD'. An anxiety disorder that develops when stunning expertise of labor is additionally called 'birth trauma'.

Track 10: Nursing and Neuro-Critical Care

Specialists are trained to diagnose patients' problems, whereas neurology nurses are specially trained to help these doctors treat patients with neurological issues. Neurology nurturing controls both immediate and post-agent thought. numerous circumstances such Parkinson's disease, brain tumours, encephalitis, scattered different sclerosis, and meningitis, as well as people who have been injured, like stroke victims and people with spinal or brain injuries. New information on all aspects of intensive neurological care is circled by Neurocritical Care. It is directed for neurosurgeons, neurologists, emergency room physicians, anesthesiologists, The book Neurocritical Care provides an overview of recent discoveries in advanced brain neurology, neuro-anesthesia, and neurosurgery as well as learning about new therapeutic avenues and technological advancements.

Track 11Psychosomatic Medicine

Psychosomatic medicine is a newly licensed sub specialty in the field of psychiatry. It is also known as consultation-liaison psychiatry. It provides knowledge, practice and instruction in the relation between mental and physical illness. This field is connected with services like diagnosis, therapeutics and research of disorders in this particular area. Hence it connects psychiatry and other medical specialties, so that psychiatrists can discuss how to manage patients with psychosomatic dysfunction.

Track 12: Clinical Neuropsychology

Clinical neuropsychology is a specialty area of ​​clinical brain research devoted to understanding the links between the brain and behavior, especially as these links can be applied to the determination of brain disorders, the assessment mental and social work and the design of effective treatment.

Track 13: Mental health Nursing

Psychiatric nursing or Mental health nursing is the appointed nurse specializes in mental health, and cares for people of all ages experiencing mental illnesses or distress. These include: schizophrenia, schizoaffective disorder, mood disorders, anxiety disorders, personality disorders, eating disorders, and suicidal thoughts, psychosis, paranoia, Alzheimer’s disease and other forms of dementia. Nurses in this area receive specific training in psychological therapies, building a therapeutic alliance, dealing with challenging behavior, and the administration of psychiatric medication.

Track 14: Neuroimmunology

Neuroimmunology as a distinct field has its origins in the fields of neurology, psychiatry, and immunology. Although neuroimmunologists initially focused on classic neuroinflammatory disorders such as multiple sclerosis and infections, there is strong evidence that the immune response leads to inherited white matter disorders, epilepsy, neurodegenerative diseases , neuropsychiatric disorders, peripheral nervous system disorders and neuro-oncological disorders, as well as aging. Our understanding of how the immune system affects the nervous system during development and aging and how these responses lead to disease as well as regeneration and repair has been greatly aided by advances in technology.

Track 15: Child and Adolescent Psychiatry

Child and adolescent psychiatry specializes in the diagnosis, treatment and prevention of mental disorders in children and adults. Child and adolescent psychiatry has the multidisciplinary channel disorder of emotion and behaviour that has its origins in neurophysiology, genetics, and environmental factors that affect child growth and development. The most common childhood mental disorders are anxiety disorders, depression and deficit hyperactivity disorder (ADHD). Normally, young people with mental disorders will have lower educational outcomes and greater involvement in the criminal justice system.

A variety of treatments are available to treat childhood mental disorders/mental illnesses, such as several effective medications, educational or vocational interventions, as well as specific types of psychotherapy, over the course of a year almost a quarter of young people and teenagers suffer from some kind of mental disorder.

Track 16: CNS

Central nervous system is the intrinsic reality of the body. Brain and the spinal cord are the core part of CNS.  Serving as the largest part of the nervous system, It regulates the thought process, the functioning of organs and movement associated with the body. The brain is encompassed in the cranial cavity and consists of neurons and glial cells. CNS is responsible for all involuntary actions

Track 17: Neuropsychiatry

Neuropsychiatry is a collaborative interface between psychiatry and neurology that account with mental disorders. The field of neuropsychiatry is engaged with understanding the link between mind, body and its behaviour. Treated as sub-specialty of psychiatry, the common cases originate from identifiable malfunctions. The amalgamation of Neuropsychiatric with neurologist and neurosurgeons provide extensive care and efficient set up for patients. Patients suffering from psychiatry conditions report. Biological psychiatry, cognitive neurosciences, behavioural neurology, and organic psychiatry are closely related fields with different motif and competence.

Track 18: Pediatric Neurology

Pediatric Neurology deals with the management and diagnosis of neurological conditions in neonates, children, infants and adolescents. The discipline of child neurology encompasses diseases and disorders of the brain, peripheral nervous system, spinal cord, autonomic nervous system and blood vessels that affect individuals in these age groups.

·         Cerebral palsy

·         Seizures/epilepsy

·         Autoimmune disorders of the nervous system

·         Headaches and Migraines

·         Stroke

·         Autism

·         Neurological disorders

·         Neuromuscular disorders

·         Neurocutaneous Syndromes

·         Metabolic disorders affecting the nervous system

Track 19: Alzheimer Disease, Ageing and Dementia

Dementia can be a general term for a decline in ability severe enough to interfere with lifestyle. Alzheimer's disease is the most common explanation for dementia. Dementia is not a traditional part of aging. It is caused by damage to brain cells that affects their ability to speak, which can affect thinking, behavior and feelings. Aging and AD are related in the way, so it is reasonable to wonder whether or not it is possible to grow old without AD appearing inexorably at all times, given the lifespan. Alzheimer's disease is strongly linked to neurodegeneration and decreased cognition, including language skills, practice, memory loss with loss of ability to recognize faces and remember names, loss of judgment and emotional stability, personality alterations, progressive and increased loss of neurons with the presence of neuritic plaques, neurofibrillary tangles, generalized destruction of the neural network, brain and evident hippocampal atrophy; however, several factors are linked to normal aging.

Track 20: Stroke and Trauma

With increased awareness of the intense impact of traumatic brain injury in recent years, a common question is whether or not traumatic brain injury can cause strokes. Many well-known athletes have spoken of traumatic brain injury and how it affected their lives years after quitting sports. Traumatic brain injury research has also found an association between traumatic brain injury and stroke. After trauma, strokes are common. Indeed, while recent concepts of stroke exclude pathologies directly related to trauma, there are still many mechanisms by which subsequent ischemia or hemorrhage may be caused by a prior traumatic event.

Track 21: Neurology

Neurology is the major branch in medical science that deals with the disorder and illnesses in the nervous system. The term neurology originates from a blend of two words - "neuron" which means nerve and "logia" signifying "the study of". The brain consists of nearly 100 billion neurons, which can generate the impulses on their own and can receive, transmit impulses from adjoining cells.

Neurology consists the study of the peripheral nervous system, the autonomic nervous system and central nervous system. The functional and structural disorders which ranges from birth defects through to degenerative diseases likely Parkinson's disease and Alzheimer's disease.

Market Analysis

The global Neurology market is forecast to grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a CAGR (compound annual growth rate) of 3.5% during this timeline. On the other hand, the global neurological biomarkers market was valued at approximately $6.1 billion in 2021. Analysts expect it to grow at a CAGR of 12.9% from 2021 to 2028. Neurological disorders comprise a large part of the population. that ranges universally from epilepsy to Alzheimer's disease and from stroke to headache. As assessed by the WHO, about 6.8 million people die each year due to neurological disorders. The economic cost of neurological disorders was estimated at 139 billion euros in 2007 in Europe.

The huge rise of the global neurological devices market shows the real example of stroke, acute and chronic diseases like epilepsy, Alzheimer's, Parkinson's, Huntington's, movement disorders, ataxia, cerebrovascular disease, multiple sclerosis, etc. An estimated 50 million US people are affected by such neurological disorders that eventually led to expensive treatment methods. Analysts think that in 2019, it would reach $13.6 billion by the current growth which will be discussed in Mental Health 2023 for the Neurology marketing device.

As the WHO has previously stated, nearly 14% of individuals were affected by any neurological disorder in 2020. The current estimate is that as of now, 50 million people have neurodegenerative diseases and analysts have calculated that this would increase to 115 million by 2050. Globally now, according to the UN report, nearly 1 in 6 of the world's population is affected by a neurological disorder with around 6.8 million people dying annually from the diseases.

There are over 600 known neurological disorders that severely affect the human nervous and muscular systems. Still, for many of the diseases, the treatment options are minimal and therefore the ongoing research should be discussed in Mental Health 2023. As per statistics, fifty million people are observed to suffer from epilepsy, sixty million people suffer from cerebrovascular diseases, three hundred and twenty-six million of the population suffer from migraines, and about 24 million people in the population have Alzheimer's disease and various other dementias, according to the California School of San Francisco. Globally, the Neurology Devices market was valued at USD 9.2 million in 2018. This value is expected to become USD 17.4 million by 2026.

Various statistics analyze that the European neurology market will have a CAGR of around 8.3% for the 2021-2028 timeline. The continued growth of various neurological disorders has increased the focus on medical device R&D, the adoption of various technological advances in healthcare, the increase in complications in the treatment of patients with recurrent stroke, and the increase in spending on the development of healthcare infrastructure, especially in developing economies. Major factors attributable to the growth of the Mental Health 2023 market.

European country level analysis   

The continent, Europe, is expected to continue to make considerable gains over the forecast period. This is due to the presence of modern and advanced healthcare technologies along with the increasing number of cases of Mental Health 2023. Germany is said to emerge as the dominant country in Europe due to increased government funds for the development of healthcare infrastructure.

European neurology market countries also provide individual market impact factors and changes in domestic market regulation. Data points including production locations and volumes, consumption volumes, price trend analysis, raw material cost, import-export analysis and upstream and downstream value chain analysis are some of the key indicators used. to forecast the market analysis for the UK. The presence and availability of global brands and the challenges they face due to high or low competition from local and domestic brands and the impact of domestic trade routes and tariffs are considered for the calculation of France's Paris forecast analysis.

For each country, a detailed market analysis is provided. The country's growth includes healthcare spending for capital equipment, the impact of technology using lifeline curves, the installed base of different types of products, and changes in healthcare regulatory landscapes.

The European market for neurological biomarkers was US$1,221.15 million in 2019 and is expected to reach US$3,062.94 million in 2027. The estimated market growth CAGR is 12.4% during this period. The market is expected to witness steady growth due to the various driving factors including the increasing occurrence of neurological disorders and intense research on neurological biomarkers. However, complications associated with the use of neurological biomarkers are expected to hamper market growth of Neuroscience

Furthermore, the increased awareness of the benefits of early diagnosis is expected to provide growth opportunities to market participants for the development of new biomarkers, while in the market, patient inclination towards personalized/delivery solutions is expected. accuracy is a continuing trend. The increase in these neurological disorders is expected to drive the growth of the market in the coming years. Globally, in 2021, the Neurology services market was worth US$2,342.9 billion and is expected to expand 1.7 times over the next ten years. The neurology services market is expected to reach $4,317.8 billion by the end of 2032, with sales revenue set to register a CAGR of 5.4% from 2022 to 2032.

The main factors driving the growth of the market are the large investments made by private players in neurology devices, the increase in R&D in the field of Neuroscience and the increase in the aging of the population. The growth of the neurology devices market in the UK is also attributed to the increasing incidence of neurological disorders which include brain aneurysms, brain tumours, epilepsy, memory disorders, multiple sclerosis, Parkinson's disease, peripheral neuropathy, post-herpetic neuralgia, tumor of the spinal cord, and stroke. Furthermore, rising healthcare spending, rising investment by medical device manufacturers and rising prevalence of neurological diseases are expected to drive the overall growth of the neurology device market in France.

The WHO has stated that around 14% of individuals will suffer from some Mental Health 2023.

European Neurological Disorder Drug Market Revenue by Region:

  • North America
  • Europe 
  • China
  • Japan
  • Middle East & Africa
  • India
  • South America
  • Others.

Past Conference Report

Mental Health 2020

Mental Health 2020

Conference series hosted 3rd Annual Congress on Mental Health November 03-04, 2020 conference.

Active participation and generous response were received from the Organizing Committee Members, scientists, researchers, as well as experts from Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events in 2020 from Conference series.

The conference was marked with several workshops, multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from scientists, young and brilliant researchers, business delegates and talented student communities representing more than 35 countries, who have driven this event into the path of success.

The conference was initiated with a warm welcome note by Honourable guests and the Keynote forum. The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers:

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Mental Health 2020 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, Conference Series would like to announce the commencement of “4th Annual Congress on Mental Health & Psychiatry

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 20-21, 2023

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

Journal of Neuroinfectious Diseases Neurological Disorders International Journal of School and Cognitive Psychology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


  • Acute Attacks
  • Acute Reperfusion Treatment
  • Acute Stroke Management
  • Addiction Nursing
  • Advance Nursing Practice
  • Advancing Human IPSC Models For Translational Research
  • Alzheimers Disease
  • Amyotrophic Lateral Sclerosis
  • Amyotrophic Lateral Sclerosis (ALS)
  • Approaches In Alzheimer`s Disease
  • Astrocytic Tumors & Brain Metastasis
  • Batten Disease
  • Behavioral Theories
  • Behavioural Neurology
  • Biomarkers In Stroke
  • Brain Development
  • Brain Hemorrhage
  • Brain Nursing
  • Brain Tumor
  • Brain Tumors
  • Care Practise: Neurology And Nursing
  • Carotid Stenosis And Cerebral Aneurysms
  • Cavernous & Arteriovenous Malformations
  • Cerebrovascular Disease
  • Chemotherapy
  • Cholesterol Tests
  • Cigarette Smoking
  • Clinical Neuropsychology
  • Clinical Trails & Case Reports
  • Cognitive Neuroscience And Dementia
  • Cognitive Therapy Treatments
  • Computed Tomography (CT )
  • Congestive Heart Failure
  • Coronary Heart Disease
  • Dementia
  • Developing Novel And Accurate Clinical Diagnostic
  • Disease Progression Biomarkers
  • Drug Mechanisms And Treatments
  • Electroencephalography (EEG)
  • Epilepsy
  • Future Research Directions In Neurological Disorders & Stroke
  • Geriatric Nursing
  • Germ Cell Tumors
  • Head Trauma
  • Headache
  • Human Behaviour
  • Human Neuroimaging
  • Hybrid PET/MRI Testing
  • Hyperactivity Disorder
  • Imaging,diagnosis And Acute Stroke Management
  • Incoordination Of Muscles
  • Infectious Disease
  • Interventional Drug Therapy
  • Latest MRI (Magnetic Resonance Imaging) Technology
  • Medulloblastomas
  • Mental Health Nursing
  • Migraines And Headaches
  • Minimally Invasive Surgery
  • Mixed Gliomas & Migraine
  • Molecular Diagnostics
  • Movement Disorders
  • Multiple Sclerosis
  • Multiple Sclerosis Disease
  • Multiple Sclerosis Treatments
  • Muscular Dystrophy
  • Neuro Nurse Practise Guidence
  • Neuro Oncology And Metatasis
  • Neurodegeneration Treatment
  • Neurogenesis
  • Neurogenesis
  • Neuroimaging
  • Neuromuscular Diseases
  • Neuropathy
  • Neuroscience
  • Neurovascular Nursing
  • Novel Tau PET Tracer
  • Novel Therapeutic Targets
  • Oligodendroglial Tumors & Seizures
  • Paediatric Oncology
  • Parkinson Disease
  • Parkinson's Disease
  • Pediatrics Nursing
  • Peripheral Nerve Surgery
  • Pharmaceuticals: Brain Power
  • Physiotherapy & Movement Disorder Treatments
  • Pre-Clincal Translational Modelling In Neurodegeneration
  • Primary-progressive Multiple Sclerosis (SPMS)
  • Prion Disease
  • Progressive-relapsing Multiple Sclerosis (PRMS)
  • Psychiatry And Psychological Disorders
  • Psychotherapy
  • Radiation Oncology
  • Radiculopathy
  • Relapsing-remitting Multiple Sclerosis (RRMS)
  • Sciatica
  • Scoliosis Spine
  • Secondary-progressive Multiple Sclerosis (SPMS)
  • Seizures And Epilepsy
  • Skull Base Surgery
  • Sleep Disorders
  • Spinal Column Anatomy
  • Spinal Cord Repair
  • Spinal Disorders
  • Spinal Stenosis
  • Spinal Stroke
  • Spine Surgery
  • Spine Tumors
  • Statins And Cholesterol
  • Stem Cell Transplantations
  • Stem Cell Transplants
  • Stereotactic Neurosurgery
  • Stroke Dementia
  • Therapeutic Approaches For Spinal Disorders
  • Tourette's Syndrome
  • Understanding Cholesterol-Lowering Medications
  • Vascular Malformations Of Brain And Spinal Cord
  • Vertigo
  • Vestibular Treatments